Osimertinib and other third-generation EGFR-TKIs are some of oncology's better plot developments. If a lung adenocarcinoma carries the right EGFR mutation, these drugs can work like a well-designed circuit breaker: they cut power to a growth signal the tumor depends on. The catch is that cancer,...
Every cell neighborhood has its gatekeepers - receptors perched on the surface, checking IDs, letting signals in, keeping riff-raff out. The IL-23 receptor has spent decades building its reputation as exactly that kind of upstanding surface citizen, standing guard on T cells and buzzing in...
Reviewed by: One Very Tired Tumor Microenvironment
Meanwhile, in the walnut-sized gland quietly minding its own business south of the bladder, a territorial dispute is unfolding. A cluster of cells has gone rogue - not dramatically, not all at once, but in the slow, methodical way that natural selection rewards: one mutation at a time, one survival...
The problem with cutaneous squamous cell carcinoma isn't just that cells grow out of control - it's that they suffer a full-blown identity crisis. Your skin cells have one job: be skin. Build a barrier. Stack up in neat layers. Stay put. But sometimes, through a molecular plot twist worthy of a spy...
Door A: You're a dendritic cell. Someone hands you a package - an mRNA vaccine wrapped in a standard lipid nanoparticle, the same delivery tech that saved civilization during COVID. You open the package, read the mRNA, and... mostly shrug. The tumor lives. Zero percent of the mice survive...
What if the tumor inside you could simply pretend to be dead while chemotherapy raged through your body, then yawn, stretch, and start growing again the moment the drugs cleared out? Not because it mutated into some indestructible supervillain, but because it pulled the biological equivalent of...
The fibroblast never planned on a career change. For years, it sat quietly in atrial tissue, minding its own business, patching up minor wear and tear like a dependable road crew filling potholes. But somewhere along the route between a breast tumor and the heart's upper chambers, a signal arrived...
That single word carries more weight in oncology than most people realize. For over half a century, I have watched the field chase shiny new molecules - and occasionally stumble upon something remarkable hiding in plain sight inside the medicine cabinet. Ponatinib, a drug that has spent the better...
Going once, going twice - sold to the oncologist recycling the same drug class! In the high-stakes auction of cancer treatment options, what happens when you've already played your best card and need to bid again with something suspiciously similar? That's the question a team of researchers just...
Ladies and gentlemen of the jury, the prosecution would like to present Exhibit A: glioblastoma multiforme (GBM), the most aggressive brain tumor known to medicine, a repeat offender with a rap sheet longer than a Law & Order marathon. For decades, the defense - our immune system - has been...
Your Gut Is Prime Real Estate - And Someone Finally Sent in an Inspector
Meanwhile, in a breast cancer cell's nucleus, thousands of long non-coding RNAs are lounging around like freeloaders at a party nobody remembers inviting them to. Scientists used to think these molecular squatters were just "junk" transcripts - the biological equivalent of that one drawer in your...
Think of your bone marrow as a building's plumbing system - a sprawling, intricate network of pipes carrying signals that tell blood cells when to grow, when to stop, and when to gracefully retire. Now imagine one of those pipes - let's call it FLT3 - develops a kink. Not the kind a plumber fixes...
Making a soufflé without a recipe is a bold move. Making one without ever having tasted a soufflé? That's basically what cancer genomics has been trying to do every time it analyzes a tumor sample without its matching "normal" DNA reference. You're staring at thousands of genetic changes, trying to...
When we last left our heroes, the plucky engineered immune cells known as CAR T cells had conquered lymphoma and myeloma with the swagger of a championship team on a winning streak. But AML - acute myeloid leukemia - remained the villain they couldn't quite crack. The tumor microenvironment was...
"But wait, there's more!" If your immune system's anti-cancer squad has been underperforming - if those T-cells are dragging themselves through the tumor microenvironment like contestants on season 47 of Survivor - then boy, does Roche have the infomercial product for you. Introducing tobemstomig:...
Members of the jury, the evidence is in. For years, the case against recurrent head and neck squamous cell carcinoma (HNSCC) has felt almost unwinnable. The prosecution - an army of surgeons, oncologists, and radiation therapists - threw everything they had at the tumor the first time around....
In Ant-Man and the Wasp, the heroes discover that the key to saving the day isn't some galaxy-sized weapon - it's mastering the quantum realm, a world so tiny it makes atoms look like beach balls. Turns out, cancer researchers have been on a remarkably similar quest. Deep inside your cells,...
A fly on the wall in the offices of JAMA this spring would have witnessed something remarkable: a polite but pointed academic cage match over one of the biggest questions in cancer medicine. On one side, three epidemiologists - Frerik Smit, Jay Kaufman, and Arnaud Chiolero - raising an eyebrow at...